Pages that link to "Item:Q4224605"
From MaRDI portal
The following pages link to Estimating treatment effects in clinical crossover trials (Q4224605):
Displaying 14 items.
- The finite sample performance of the two-stage analysis of a two-period crossover trial (Q310650) (← links)
- A joint model for incomplete data in crossover trials (Q984639) (← links)
- Inference on interactions between treatments and subjects within groups in a two-period crossover trial (Q1580007) (← links)
- Randomized response model versus mixture model in the crossover design for clinical trials (Q2816442) (← links)
- Local Influence Analysis in AB-BA Crossover Designs (Q2932779) (← links)
- Notes on estimation of the proportion ratio in the presence of carryover effects under the AB/BA crossover trial (Q2965611) (← links)
- The use of baseline covariates in crossover studies (Q3303580) (← links)
- On Determining the Effects of Therapy on Disease Damage in Non Randomized Studies with Multiple Treatments: A Study of Juvenile Myositis (Q3652651) (← links)
- Analysis of incomplete data in a two-period crossover design with reference to clinical trials (Q3745133) (← links)
- Circular First- and Second-Order Balanced Repeated Measurements Designs (Q5190597) (← links)
- Cross effects and calculus in an unbased setting (Q5264935) (← links)
- An objective Bayesian estimation in a two-period crossover design (Q5368782) (← links)
- Randomization and Additivity in the Two‐Period Crossover Clinicial Trial (Q5750256) (← links)
- Cross-over trials in drug development: Theory and practice (Q5939490) (← links)
